Allergic clinical trials

Explore recruiting allergic clinical trials.

Recruiting allergic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allergic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase IV, open, non-randomised, low-intervention clinical trial to evaluate the subjective user experience of Zeqmelit™ 6 mg mouth dissolving film for treatment of acute allergic reaction

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

Omalizumab for monotherapy treatment of patients with food allergies to plant-based foods due to sensitization to LTP and profilin

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice - ALLERDOG SWEDEN

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure

Austria, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescent and adult patients with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.

Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pilot study of the pharmacokinetic profile of paracetamol subcutaneously versus intravenously in patients in a palliative situation

France

Phase II and Phase III (Integrated) EU CTIS Study details

Allergic trials by city

Allergic in Toronto Allergic in Vancouver Allergic in Montreal Allergic in Calgary Allergic in Edmonton Allergic in Ottawa Allergic in Winnipeg Allergic in Quebec City Allergic in Hamilton Allergic in Kitchener Allergic in London Allergic in Halifax Allergic in New York Allergic in Los Angeles Allergic in Chicago Allergic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease